Literature DB >> 8683679

Endoscopic ureteroneocystostomy for complete obstruction at the ureterovesical junction.

S E Strup1, D H Bagley.   

Abstract

PURPOSE: We evaluated the technical and long-term success of endoscopic ureteroneocystostomy in patients with complete obstruction of the distal ureter.
MATERIALS AND METHODS: We treated 7 patients with complete obstruction at the ureterovesical junction via a combined antegrade and retrograde endoscopic approach (endoscopic ureteroneocystostomy). The etiology of obstruction included ureteroscopy for ureteral calculi in 3 patients and previous resection of bladder tumors or the prostate in 4. Six patients had proximal drainage with a percutaneous nephrostomy catheter at referral. An antegrade approach was used for localization, and a retrograde approach was used for direct visual ureteral meatotomy or ureterotomy with the endoscopic scissors or a cold-knife urethrotome.
RESULTS: Continuity at the ureterovesical junction was restored in all 7 patients, and 6 are currently stricture-free with followup of 14 to 64 months. The sole failure in this series was due to recurrent invasive transitional cell carcinoma.
CONCLUSIONS: Endoscopic ureteroneocystostomy is a safe and effective treatment of complete obstruction of the ureterovesical junction.

Entities:  

Mesh:

Year:  1996        PMID: 8683679     DOI: 10.1097/00005392-199608000-00007

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

Review 1.  Current status of minimally invasive endoscopic management of ureteric strictures.

Authors:  Stefanos Kachrilas; Andreas Bourdoumis; Theocharis Karaolides; Stavroula Nikitopoulou; George Papadopoulos; Noor Buchholz; Junaid Masood
Journal:  Ther Adv Urol       Date:  2013-12

2.  Endoscopic treatment of ureterovesical junction obstructive pathology: A description of the oblique meatotomy technique and results.

Authors:  Miguel Arrabal-Martín; Armando Zuluaga-Gómez; Sergio Merino-Salas; Mercedes Nogueras-Ocaña; Miguel Ángel Arrabal-Polo
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.